arrow
T

T. Pudlarz

Department of Cancer Medicine
H指数:10
被引数:695

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrating Tumor Volumetry and Liquid Biopsy: a New Model to Define Prognosis in Advanced Pancreatic Ductal Adenocarcinoma

整合肿瘤体积测量和液体活检:一种定义晚期胰腺导管腺癌预后的新模型

2026-05-010
PRE
Targeting the Liver: Insights from a tertiary center on post-operative hepatic arterial oxaliplatin for Metastatic Colorectal Cancer

靶向肝脏:来自一家三级中心关于转移性结直肠癌术后肝动脉奥沙利铂灌注的见解

2026-03-030
PRE
Correction: Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care
2026-01-200
PRE
Lung-only metastatic pancreatic cancer: differences in patients ‘characteristics, molecular profile and survival

肺转移性胰腺癌:患者特征、分子谱和生存差异

2026-01-090
PRE
Comprehensive molecular landscape of anal squamous cell carcinoma: analysis of tissue and liquid biopsies from 1844 patients

肛门鳞状细胞癌的全面分子图谱:1844例患者的组织活检和液体活检分析

2025-11-240
OAAI
Impact of oncology review meetings on second opinions for patients with gastrointestinal cancer

肿瘤学评审会议对胃肠道癌患者二次诊疗意见的影响

2025-09-200
PRE
Young-Onset Biliary Tract Cancers: Characteristics, Treatment Patterns, and Patient Outcomes

早发型胆道系统癌症:特征、治疗模式及患者预后

2025-08-110
OAAI
Diagnostic relevance of p53 and Rb status in neuroendocrine tumors G3 from different organs: an immunohistochemical study of 465 high-grade neuroendocrine neoplasms

不同器官来源的神经内分泌肿瘤G3中p53和Rb状态的诊断相关性: 465高级别神经内分泌肿瘤的免疫组织化学研究

2024-12-130
PRE
Tertiary cancer prevention: A national evaluation of the practices and perceptions of hospital-based health care professionals (HHCPs) in charge of the follow-up (FU) care of cancer

三级癌症预防:一项针对负责癌症随访(FU)护理的医院-based卫生保健专业人员(HHCPs)的实践和认知的国家评估

2024-12-010
PRE
Clinical and molecular features of early onset pancreatic adenocarcinoma

早发性胰腺癌的临床和分子特征

2024-08-150
OA